Fri, 17 March 2023
On this episode of Investor Connect, Hall welcomes Yaniv Sneor, Founder of Mid Atlantic Bio Angels (MABA).
Mid Atlantic Bio Angels is a NY-based life science angel investment group that was formed in 2012 with the goal of bringing together the expertise required by investors to make informed investment decisions in scientific, regulatory, and commercially-complex healthcare investment opportunities. MABA invests exclusively in early-stage, private life science companies (primarily therapeutics, devices, diagnostics, and some digital health), with no geographic restrictions.
Participation in MABA is limited to accredited individuals and corporate MABA members who are actively involved in company screenings and diligence, requiring a time and financial commitment, as well as scientific, regulatory, and commercial expertise in the life sciences.
Yaniv Sneor is one of the founders of MABA, where he also administers MABA’s internal investment pools, and MABA’s co-investment Sidecar Fund, for non-MABA member investors.
Yaniv is originally a physicist, who made the transition into the business world about 30 years ago, at which point he took the helm of his first company. Mr. Sneor has senior merger, acquisition, capitalization, and turnaround leadership experience with companies ranging from start-ups to growth. He has held positions of CEO, COO, President, and General Manager at a number of companies, including a bio-informatics company, a surgical laser company, a manufacturing and distribution company, a software and network integration company, and several others.
Yaniv discusses what it means to be a life science angel investment group, the challenges that they face, and the rewards of working in this field.
For more episodes from Investor Connect, please visit the site at: http://investorconnect.org
Check out our other podcasts here: https://investorconnect.org/
For Feedback please contact email@example.com
Please follow, share, and leave a review.
Music courtesy of Bensound.